Photos from Envato
Technologies such as genomics, neuroimaging and biomarker analysis have driven growth.
Research and markets say the Alzheimer's drug market is expected to reach $16.43B by 2033, with a CAGR of about 9%.
The industry’s expansion is attributed to the prevalence of Alzheimer’s disease, the development of drug development, and increased government and private financing of research on neurological diseases.
“To speed up market access, regulators are streamlining the approval process for drugs used to treat Alzheimer's disease,” the report said.
Meanwhile, technologies such as genomics, neuroimaging and biomarker analysis make clinical trials and drug efficacy evaluation easier, thus helping market growth.
Join the Healthcare Asia Magazine Community
Since you're here…
…You can promote your company with us and connect with your customers in a variety of ways. Our team can help you Dight and create advertising campaigns on print and digitally on this website and on print magazines.
We can also organize real-life or digital events for you and find thought leader speakers and industry leaders who can become your potential partners to attend. We also run a number of award programs that give you the opportunity to earn your achievements this year, and you can join as a participant or sponsor.
Let us help you move your business forward with a good partnership!
